Description |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Roche Pharma |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Getz Pharma |
Trastuzumab 440mg/10ml |
Product Type |
Product Size |
Tablet |
60'S |
Product Company |
Pharma Solution |
Sorafenib 500mg |
Product Type |
Product Size |
Product Company |
Injection |
1'S |
Searle Pharma |
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Helix pharma |
Methotrexate 50mg/2ml
|
Product Type |
Product Size |
Injection |
1'S |
Product Company |
Roche Pharma |
Pertuzumab 420mg/14ml |
Content | "
Rituximab is a biological therapy used for rheumatoid arthritis, lupus, vasculitis and dermatomyositis | Trastuzumab is a monoclonal anti-human epidermal growth factor receptor 2 protein antibody used to treat HER2-positive breast, gastroesophageal, and gastric cancers. | Sorafenib is used to treat late-stage kidney cancer (advanced renal cell carcinoma), liver cancer (hepatocellular carcinoma) that cannot be treated by surgery, and differentiated thyroid cancer that has come back or spread to other parts of your body.
| Rituximab, an anti CD20 monoclonal antibody, is used in the management of lymphoproliferative and autoimmune conditions. | Methotrexate is an antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis.
| "
Pertuzumab is a monoclonal antibody. . Monoclonal antibodies work by attaching to proteins on or in cancer cells. Human epidermal growth factor 2 (HER2) is a protein that makes cells grow and divide. |
Reviews
There are no reviews yet.